These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32917127)

  • 1. Serum Kynurenines Correlate With Depressive Symptoms and Disability in Poststroke Patients: A Cross-sectional Study.
    Carrillo-Mora P; Pérez-De la Cruz V; Estrada-Cortés B; Toussaint-González P; Martínez-Cortéz JA; Rodríguez-Barragán M; Quinzaños-Fresnedo J; Rangel-Caballero F; Gamboa-Coria G; Sánchez-Vázquez I; Barajas-Martínez K; Franyutti-Prado K; Sánchez-Chapul L; Ramírez-Ortega D; Ramos-Chávez LA
    Neurorehabil Neural Repair; 2020 Oct; 34(10):936-944. PubMed ID: 32917127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kynurenine pathway metabolites are associated with hippocampal activity during autobiographical memory recall in patients with depression.
    Young KD; Drevets WC; Dantzer R; Teague TK; Bodurka J; Savitz J
    Brain Behav Immun; 2016 Aug; 56():335-42. PubMed ID: 27091600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations of Kynurenic Acid, 3-Hydroxykynurenine, sIL-2R, IFN-α, and IL-4 with Clinical Symptoms During Acute Relapse of Schizophrenia.
    Szymona K; Zdzisińska B; Karakuła-Juchnowicz H; Kocki T; Kandefer-Szerszeń M; Flis M; Rosa W; Urbańska EM
    Neurotox Res; 2017 Jul; 32(1):17-26. PubMed ID: 28275903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
    Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
    Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poststroke depression: prevalence and determinants in Brazilian stroke patients.
    Carod-Artal FJ; Ferreira Coral L; Trizotto DS; Menezes Moreira C
    Cerebrovasc Dis; 2009; 28(2):157-65. PubMed ID: 19556768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Metabolic Profiles of the Tryptophan-Kynurenine Pathway in the high risk subjects of major depressive disorder.
    Sakurai M; Yamamoto Y; Kanayama N; Hasegawa M; Mouri A; Takemura M; Matsunami H; Miyauchi T; Tokura T; Kimura H; Ito M; Umemura E; Boku AS; Nagashima W; Tonoike T; Kurita K; Ozaki N; Nabeshima T; Saito K
    Sci Rep; 2020 Feb; 10(1):1961. PubMed ID: 32029791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kynurenic acid is reduced in females and oral contraceptive users: Implications for depression.
    Meier TB; Drevets WC; Teague TK; Wurfel BE; Mueller SC; Bodurka J; Dantzer R; Savitz J
    Brain Behav Immun; 2018 Jan; 67():59-64. PubMed ID: 28867283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep disturbance and kynurenine metabolism in depression.
    Cho HJ; Savitz J; Dantzer R; Teague TK; Drevets WC; Irwin MR
    J Psychosom Res; 2017 Aug; 99():1-7. PubMed ID: 28712413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum kynurenic acid is reduced in affective psychosis.
    Wurfel BE; Drevets WC; Bliss SA; McMillin JR; Suzuki H; Ford BN; Morris HM; Teague TK; Dantzer R; Savitz JB
    Transl Psychiatry; 2017 May; 7(5):e1115. PubMed ID: 28463241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway.
    Guloksuz S; Arts B; Walter S; Drukker M; Rodriguez L; Myint AM; Schwarz MJ; Ponds R; van Os J; Kenis G; Rutten BP
    Brain Behav Immun; 2015 Aug; 48():48-52. PubMed ID: 25765557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of repetitive transcranial magnetic stimulation on the kynurenine pathway in stroke patients.
    Niimi M; Ishima T; Hashimoto K; Hara T; Yamada N; Abo M
    Neuroreport; 2020 Jun; 31(9):629-636. PubMed ID: 32427708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is poststroke depression a major depression?
    da Rocha e Silva CE; Alves Brasil MA; Matos do Nascimento E; de Bragança Pereira B; André C
    Cerebrovasc Dis; 2013; 35(4):385-91. PubMed ID: 23635428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poststroke depression and its multifactorial nature: results from a prospective longitudinal study.
    De Ryck A; Fransen E; Brouns R; Geurden M; Peij D; Mariën P; De Deyn PP; Engelborghs S
    J Neurol Sci; 2014 Dec; 347(1-2):159-66. PubMed ID: 25451004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder.
    Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Ning Y
    Psychoneuroendocrinology; 2019 Mar; 101():72-79. PubMed ID: 30419374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Association of Serum BDNF With Poststroke Depression and Poststroke Anxiety.
    Han Z; Wang Y; Qi L; Wang J; Wong J; Chen J; Luo X; Wang QM
    Arch Phys Med Rehabil; 2020 Aug; 101(8):1355-1366. PubMed ID: 32416148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Post-stroke Depressive Symptoms are Associated with Low Peripheral Levels of Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) and Glial Cell-derived Neurotrophic Factor (GDNF).
    Pedroso VSP; Vieira ÉLM; de Miranda AS; Venna VR; McCullough LD; Teixeira AL
    Curr Neurovasc Res; 2020; 17(4):495-501. PubMed ID: 32819258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum concentrations of kynurenines in adult patients with attention-deficit hyperactivity disorder (ADHD): a case-control study.
    Aarsland TI; Landaas ET; Hegvik TA; Ulvik A; Halmøy A; Ueland PM; Haavik J
    Behav Brain Funct; 2015 Nov; 11(1):36. PubMed ID: 26542774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder.
    Savitz J; Dantzer R; Wurfel BE; Victor TA; Ford BN; Bodurka J; Bellgowan PS; Teague TK; Drevets WC
    Psychoneuroendocrinology; 2015 Feb; 52():200-11. PubMed ID: 25486577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of indoleamine 2,3-dioxygenase expression and kynurenine pathway metabolites levels in serum samples of diabetic retinopathy patients.
    Munipally PK; Agraharm SG; Valavala VK; Gundae S; Turlapati NR
    Arch Physiol Biochem; 2011 Dec; 117(5):254-8. PubMed ID: 22034910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kynurenine pathway changes in late-life depression.
    Wu Y; Zhong X; Mai N; Wen Y; Shang D; Hu L; Chen B; Zhang M; Ning Y
    J Affect Disord; 2018 Aug; 235():76-81. PubMed ID: 29655078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.